Journal article icon

Journal article

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism

Abstract:
Introduction: Ghrelin is a potent orexigenic brain-gut peptide with lipogenic and diabetogenic effects, possibly mediated by growth hormone secretagogue receptor (GHS-R1a). Cannabinoids also have orexigenic and lipogenic effects. AMPK is a regulator of energy homeostasis and we have previously shown that ghrelin and cannabinoids stimulate hypothalamic AMPK activity while inhibiting it in the liver and adipose tissue, suggesting that AMPK mediates both the central appetite-inducing and peripheral effects of ghrelin and cannabinoids. Aims: Using GHS-R KO mice, we investigated whether the known ghrelin receptor GHS-R1a is required for the tissue-specific effects of ghrelin on AMPK activity, and if an intact ghrelin signalling pathway is necessary for the effects of cannabinoids on AMPK activity. Methods: Wild-type and GHS-R KO mice were treated intraperitoneally with ghrelin 500. ng/g bodyweight or CB1 agonist HU210 20. ng/g and hypothalamic, hepatic and adipose AMPK activity was studied using a functional kinase assay. Results: Ghrelin and HU210 significantly stimulated hypothalamic AMPK activity in wild-type animals (mean ± SEM, 122.5 ± 5.2% and 128 ± 11.6% of control, p<0.05) and inhibited it in liver (55.1 ± 4.8% and 62.2 ± 14.5%, p<0.01) and visceral fat (mesenteric fat (MF): 54.6 ± 16% and 52.0 ± 9.3%, p<0.05; epididymal fat (EF): 47.9 ± 12.1% and 45.6 ± 1.7%, p<0.05). The effects of ghrelin, and interestingly also HU210, on hypothalamic, visceral fat and liver AMPK activity were abolished in the GHS-R KO mice (hypothalamus: 107.9 ± 7.7% and 87.4 ± 13.3%, liver: 100.5 ± 11.6% and 116.7 ± 5.4%, MF: 132.1 ± 29.9% and 107.1 ± 32.7%, EF: 89.8 ± 7.3% and 91.7 ± 18.3%, p>0.05). Conclusions: Ghrelin requires GHS-R1a for its effect on hypothalamic, liver and adipose tissue AMPK activity. An intact ghrelin signalling pathway is necessary for the effects of cannabinoids on AMPK activity. © 2012 Elsevier Ireland Ltd.

Actions


Access Document


Publisher copy:
10.1016/j.mce.2012.11.007

Authors



Journal:
Molecular and Cellular Endocrinology More from this journal
Volume:
365
Issue:
2
Pages:
303-308
Publication date:
2013-01-03
DOI:
EISSN:
1872-8057
ISSN:
0303-7207


Language:
English
Keywords:
Pubs id:
pubs:371469
UUID:
uuid:388ca9e5-29b1-45cd-9c6b-9bde69cdbf5e
Local pid:
pubs:371469
Source identifiers:
371469
Deposit date:
2013-11-16

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP